FDA Approves Sublocade (buprenorphine) Once-Monthly Injection for Opioid Use Disorder

Article Link: FDA Approves Sublocade (buprenorphine) Once-Monthly Injection for Opioid Use Disorder

November 30, 2017 — The U.S. Food and Drug Administration today approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use disorder (OUD) in adult patients who have initiated…

Source: FDA New Drug Approvals